Navigation Links
News tips from the journal mBio®, volume 4, issue 1
Date:3/14/2013

Disarming One of the Deadliest Pathogens

Francisella tularensis, the cause of tularemia and one of the deadliest respiratory pathogens in existence, is considered a potential biological weapon because it is readily aerosolized and exhibits a high degree of infectivity and lethality in humans. While a live attenuated vaccine strain has been developed, it remains unlicensed because scientists have been unable to understand the basis for its attenuated virulence. In an attempt to find an acceptable live attenuated vaccine strain, researchers from Harvard Medical School examined the mechanism behind one reason the pathogen is so lethal. The first line of defense against a bacterial pathogen is innate immunity, which slows the progress of infection to allow time for adaptive immunity to develop. F. tularensis suppresses the early innate immune response, allowing the pathogen to kill its host before adaptive immunity develops, using a specific lipopolysaccharide (LPS.) In this study the researchers show that a strain of the pathogen lacking this specific LPS is attenuated in mice and specifically elicits an innate immune response. When immunized with the strain, mice were protected against challenge by a highly virulent strain of the bacteria. This study has identified not only a novel LPS modification important for microbial virulence, but also offers a new vaccine candidate.

http://bit.ly/mbiotip0313a


Lessons from a Decade of Plague in a Port City

A cluster of human plague cases over a 10-year period in the seaport city of Mahajanga Madagascar after a 62-year plague-free period provided researchers from Arizona and Madagascar with an opportunity to study plague dynamics in an urban environment, especially since historically plague entered new geographic areas through port cities such as this. Most of the isolates found during t
'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Tips from the journal mBio
2. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
3. Flavor and the new Nordic cuisine: BioMed Centrals new scientific journal Flavor is launched
4. Elsevier launches new journal Algal Research
5. AGU journal highlights for March 29, 2012
6. AGU journal highlights for April 16, 2012
7. Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry
8. New journal on disruptive science and technology launched by Mary Ann Liebert Inc. publishers
9. Wiley-Blackwell launches new open-access journal: Food Science & Nutrition
10. Special issue of the EMBO Journal celebrates 30 years of Wnt research
11. New peer-reviewed journal on big data launching in Fall 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, reminds investors and media that  Mr. ...  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of nine ... Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... The founder of a public database that helps doctors ... decisions is the 2009 recipient of the March of ... field of genetic sciences. Roberta "Bonnie" Pagon, MD, ... of Medicine in Seattle, developed the Web site genetests.org ...
... have observed the initiation of a mass gathering and subsequent ... case, fish. The work, conducted using a novel imaging ... that vast oceanic fish shoals inhabit," the team writes in ... also confirms theories about the behavior of large groups of ...
... unveiled the evolutionary origin of the different chromosomal ... comprehensive comparison of the Agrobacterium sequence information with ... general model for how second chromosomes are formed ... Rhizobiaceae family, which also includes the benign, nitrogen-fixing ...
Cached Biology News:Roberta A. Pagon receives lifetime award in genetics from March of Dimes 2Team IDs genesis of mass migrations 2Team IDs genesis of mass migrations 3Evolutionary origin of bacterial chromosomes revealed 2
(Date:5/26/2015)... REDWOOD CITY , Kalifornien und HILDEN, ... QIAGEN Clinical Insight ... Interpretation von Genvarianten und die Erstellung dazugehöriger ... und ESHG     QIAGEN N.V. ... QIA) gab heute die Markteinführung von QIAGEN ...
(Date:5/26/2015)... -- Alere Inc. (NYSE: ALR ) (the "Company") announced today ... its Quarterly Report on Form 10-Q for the three months ... a notice from the New York Stock Exchange (the "NYSE") ... continued listing requirements under the timely filing criteria established in ... The reason for the delay relates to Company,s need ...
(Date:5/26/2015)... , May 26, 2015   PDI ... solutions, today announced that Oakwood Healthcare in ... as the winning entry in Delivering ... professionals who display excellence in building collaborative relationships ... teams in healthcare facilities.  Oakwood ...
(Date:5/26/2015)... Kevin Xu , prezident MEBO ... Obamovi a Billovi Clintonovi za ich kondolencie a ... Rongxiang Xu , otca Kevina. ... Xu bol pionier, inovátor, humanitárny pracovník a vodca ... vedy a príkladné vedenie svojej komunity zanecháva odkaz, ...
Breaking Biology Technology:QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3Dr. Rongxiang Xu, O legende 2
... Board of Directors of the Pittsburgh Life Sciences Greenhouse ... formation and business growth services to the region,s life ... of Peter M. DeComo as the new Chairman of ... will replace Dr. D. Lansing Taylor who is stepping ...
... hair-like blood vessels in the back of our eyes, researchers ... those that bring blood to the heart respond to air ... otherwise healthy people exposed to high levels of air pollution ... of heart disease. Previous studies linked pollution to heart ...
... In 2008, experiments at The Fu Foundation School of ... graphene, a single layer of graphite only one atom ... raised a question for Chris Marianetti, Assistant Professor in ... how and why does graphene break? ...
Cached Biology Technology:The Pittsburgh Life Sciences Greenhouse Announces New Chairman of the Board 2Photos of tiny blood vessels in the eye link air pollution to heart disease 2Columbia engineering team discovers graphene's weakness 2
Recognizes a full-length CLC-2 voltage-gated Cl- protein and not with other known proteins tested so far....
... 2 - BSA and Azide free ... applications). Antigen: ... corresponding to C terminal amino acids ... Entrez GeneID: 2064 ...
Potassium Channel kv3.2...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: